+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Active Pharmaceutical Ingredients Market 2021-2028

  • PDF Icon

    Report

  • 254 Pages
  • February 2022
  • Region: Global
  • GMD Research
  • ID: 5118597
Global active pharmaceutical ingredients market will reach $334 billion by 2028, growing by 6.9% annually over 2021-2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.



Highlighted with 146 tables and 104 figures, this 254-page report “Global Active Pharmaceutical Ingredients (API) Market 2021-2028 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global active pharmaceutical ingredients market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2028 with 2021 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global active pharmaceutical ingredients market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Region.

Based on Synthesis, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.


Synthetic API

  • Branded Synthetic API
  • Generic Synthetic API

Biotech API by Drug Type:

  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Other Biotech APIs

Biotech API by Customer Base:

  • Innovative Biologic API
  • Generic Biosimilar API

Biotech API by Expression Technology:

  • Mammalian Expression
  • Microbial Expression
  • Yeast Expression
  • Insect Expression
  • Other Expression Technologies

HPAPI

  • Branded HPAPI
  • Generic HPAPI

Based on Manufacturing Process, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.


Captive Manufacturing

  • Branded Captive API
  • Generic Captive API

Merchant Manufacturing by Drug Type:

  • Branded Merchant API
  • Generic Merchant API

Merchant Manufacturing by Drug Synthesis:

  • Merchant Synthetic API
  • Merchant Biotech API

By Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.

  • Infectious Diseases
  • Oncology
  • Ophthalmology
  • Cardiovascular Disorders
  • Central Nervous System
  • Pulmonary Disorders
  • Orthopedics
  • Other Applications

By Drug Type, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.

  • Branded Prescription Drugs
  • Generic Prescription Drugs
  • OTC Drugs

Geographically, the following regions together with the listed national/local markets are fully investigated:

  • North America (U.S., Canada, and Mexico)
  • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Indonesia, Malaysia, New Zealand, Singapore, Thailand, and Vietnam)
  • South America (Brazil, Chile, Argentina, Rest of South America)
  • MEA (UAE, Saudi Arabia, South Africa, Other Nations)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ bn) are available for 2018-2028. The breakdown of all regional markets by country and split of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application, over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

  • AbbVie Inc.
  • Astrazeneca
  • Aurobindo Pharma Ltd.
  • BASF
  • Bayer AG
  • Boehringer Ingelheim
  • Catalent Inc.
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche
  • GlaxoSmithKline plc
  • Lonza Group
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Frequently Asked Questions about the Global Active Pharmaceutical Ingredients (API) Market

What is the estimated value of the Global Active Pharmaceutical Ingredients (API) Market?

The Global Active Pharmaceutical Ingredients (API) Market was estimated to be valued at $208900 Million in 2021.

What is the growth rate of the Global Active Pharmaceutical Ingredients (API) Market?

The growth rate of the Global Active Pharmaceutical Ingredients (API) Market is 6.9%, with an estimated value of $334000 Million by 2028.

What is the forecasted size of the Global Active Pharmaceutical Ingredients (API) Market?

The Global Active Pharmaceutical Ingredients (API) Market is estimated to be worth $334000 Million by 2028.

Who are the key companies in the Global Active Pharmaceutical Ingredients (API) Market?

Key companies in the Global Active Pharmaceutical Ingredients (API) Market include Selected Key Players:, AbbVie Inc., Astrazeneca, Aurobindo Pharma Ltd., BASF, Bayer AG, Boehringer Ingelheim, Catalent Inc. and F. Hoffmann.

Table of Contents

1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis
3 Segmentation of Global Market by Synthesis
3.1 Market Overview by Synthesis
3.2 Synthetic API
3.2.1 Branded Synthetic API
3.2.2 Generic Synthetic API
3.3 Biotech API
3.3.1 Biotech API by Drug Type
3.3.1.1 Monoclonal Antibodies
3.3.1.2 Recombinant Proteins
3.3.1.3 Vaccines
3.3.1.4 Other Biotech APIs
3.3.2 Biotech API by Category
3.3.2.1 Innovative Biologic API
3.3.2.2 Generic Biosimilar API
3.3.3 Biotech API by Expression Technology
3.3.3.1 Mammalian Expression
3.3.3.2 Microbial Expression
3.3.3.3 Yeast Expression
3.3.3.4 Insect Expression
3.3.3.5 Other Expression Technologies
3.4 HPAPI
3.4.1 Branded HPAPI
3.4.2 Generic HPAPI
4 Segmentation of Global Market by Manufacturing Process
4.1 Market Overview by Manufacturing Process
4.2 Captive Manufacturing
4.2.1 Branded Captive API
4.2.2 Generic Captive API
4.3 Merchant Manufacturing
4.3.1 Merchant Manufacturing by Drug Type
4.3.1.1 Branded Merchant API
4.3.1.2 Generic Merchant API
4.3.2 Merchant Manufacturing by Drug Synthesis
4.3.2.1 Merchant Synthetic API
4.3.2.2 Merchant Biotech API
5 Segmentation of Global Market by Therapeutic Application
5.1 Market Overview by Therapeutic Application
5.2 Infectious Diseases
5.3 Oncology
5.4 Ophthalmology
5.5 Cardiovascular Disorders
5.6 Central Nervous System
5.7 Pulmonary Disorders
5.8 Orthopedics
5.9 Other Applications
6 Segmentation of Global Market by Drug Type
6.1 Market Overview by Drug Type
6.2 Branded Prescription Drugs
6.3 Generic Prescription Drugs
6.4 OTC Drugs
7 Segmentation of Global Market by Region
7.1 Geographic Market Overview 2021-2028
7.2 North America Market 2021-2028 by Country
7.2.1 Overview of North America Market
7.2.2 U.S.
7.2.3 Canada
7.2.4 Mexico
7.3 European Market 2021-2028 by Country
7.3.1 Overview of European Market
7.3.2 UK
7.3.3 France
7.3.4 Germany
7.3.5 Spain
7.3.6 Italy
7.3.7 Russia
7.3.8 Rest of European Market
7.4 Asia-Pacific Market 2021-2028 by Country
7.4.1 Overview of Asia-Pacific Market
7.4.2 China
7.4.3 Japan
7.4.4 India
7.4.5 Australia
7.4.6 South Korea
7.4.7 Rest of APAC Region
7.5 South America Market 2021-2028 by Country
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America Market
7.6 Rest of World Market 2021-2028 by Country
7.6.1 UAE
7.6.2 Saudi Arabia
7.6.3 South Africa
7.6.4 Other National Markets
8 Competitive Landscape
8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
  • AbbVie Inc.
  • Astrazeneca
  • Aurobindo Pharma Ltd.
  • BASF
  • Bayer AG
  • Boehringer Ingelheim
  • Catalent Inc.
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche
  • GlaxoSmithKline plc
  • Lonza Group
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific

9 Investing in Global Market: Risk Assessment and Management
9.1 Risk Evaluation of Global Market
9.2 Critical Success Factors (CSFs)

List of Tables:

Table 1. Snapshot of Global Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2021-2028
Table 2. World Economic Outlook, 2021-2031
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 4. Main Product Trends and Market Opportunities in Global Active Pharmaceutical Ingredients (API) Market
Table 5. Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 6. Global Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2018-2028, $ bn
Table 7. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2018-2028, $ bn
Table 8. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2018-2028, $ bn
Table 9. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2018-2028, $ bn
Table 10. Global Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2018-2028, $ bn
Table 11. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 12. Global Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2018-2028, $ bn
Table 13. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2018-2028, $ bn
Table 14. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2018-2028, $ bn
Table 15. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 16. Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2018-2028, $ bn
Table 17. Global Active Pharmaceutical Ingredients (API) Market by Region, 2018-2028, $ bn
Table 18. World Health Spending by Region, $ bn, 2013-2020
Table 19. Leading National Active Pharmaceutical Ingredients (API) Market, 2021 and 2028, $ bn
Table 20. North America Active Pharmaceutical Ingredients (API) Market by Country, 2018-2028, $ bn
Table 21. U.S. Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 22. U.S. Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 23. U.S. Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 24. Top 15 Countries Supplying API for Medicines Consumed in the US, 2019, % based on Dollar Value
Table 25. Canada Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 26. Canada Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 27. Canada Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 28. Mexico Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 29. Mexico Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 30. Mexico Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 31. Europe Active Pharmaceutical Ingredients (API) Market by Country, 2018-2028, $ bn
Table 32. UK Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 33. UK Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 34. UK Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 35. France Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 36. France Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 37. France Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 38. Germany Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 39. Germany Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 40. Germany Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 41. Spain Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 42. Spain Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 43. Spain Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 44. Italy Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 45. Italy Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 46. Italy Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 47. Russia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 48. Russia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 49. Russia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 50. Active Pharmaceutical Ingredients (API) Market in Rest of Europe by Country, 2018-2028, $ bn
Table 51. APAC Active Pharmaceutical Ingredients (API) Market by Country, 2018-2028, $ bn
Table 52. China Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 53. China Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 54. China Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 55. Japan Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 56. Japan Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 57. Japan Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 58. India Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 59. India Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 60. India Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 61. Australia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 62. Australia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 63. Australia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 64. South Korea Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 65. South Korea Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 66. South Korea Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 67. Active Pharmaceutical Ingredients (API) Market in Rest of APAC by Country, 2018-2028, $ bn
Table 68. South America Active Pharmaceutical Ingredients (API) Market by Country, 2018-2028, $ bn
Table 69. Argentina Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 70. Argentina Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 71. Argentina Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 72. Brazil Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 73. Brazil Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 74. Brazil Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 75. Chile Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 76. Chile Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 77. Chile Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 78. RoW Active Pharmaceutical Ingredients (API) Market by Country, 2018-2028, $ bn
Table 79. UAE Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 80. UAE Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 81. UAE Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 82. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 83. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 84. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 85. South Africa Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 86. South Africa Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 87. South Africa Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 88. AbbVie Inc.: Company Snapshot
Table 89. AbbVie Inc.: Product Portfolio
Table 90. AbbVie Inc.: Revenue, 2018-2020, $ bn
Table 91. Astrazeneca: Company Snapshot
Table 92. Astrazeneca: Revenue, 2018-2020, $ bn
Table 93. Aurobindo Pharma Ltd.: Company Snapshot
Table 94. Aurobindo Pharma Ltd.: Product Portfolio
Table 95. BASF: Company Snapshot
Table 96. BASF: Business Segmentation
Table 97. BASF: Revenue by Region
Table 98. Bayer AG: Company Snapshot
Table 99. Bayer AG: Business Segmentation
Table 100. Bayer AG: Revenue, 2018-2020, € bn
Table 101. Boehringer Ingelheim: Company Snapshot
Table 102. Boehringer Ingelheim: Business Segmentation in 2019
Table 103. Boehringer Ingelheim: Product Portfolio
Table 104. Boehringer Ingelheim: Revenue, 2018-2020, EUR billion
Table 105. Boehringer Ingelheim: Revenue by Region in 2019
Table 106. Catalent Inc.: Company Snapshot
Table 107. Catalent Inc.: Business Segmentation in 2018
Table 108. Catalent Inc.: Product Portfolio
Table 109. Catalent Inc.: Revenue, 2018-2020, $ million
Table 110. Catalent Inc.: Revenue by Region in 2018
Table 111. Dr. Reddy's Laboratories: Company Snapshot
Table 112. Dr. Reddy's Laboratories: Business Segmentation
Table 113. Dr. Reddy's Laboratories: Revenue, 2019-2021, $ bn
Table 114. F. Hoffmann-La Roche: Company Snapshot
Table 115. F. Hoffmann-La Roche: Business Segmentation
Table 116. GlaxoSmithKline: Company Snapshot
Table 117. GlaxoSmithKline: Business Segmentation
Table 118. GlaxoSmithKline: Product Portfolio
Table 119. GlaxoSmithKline: Revenue, 2018-2020, $ bn
Table 120. Lonza Group: Company Snapshot
Table 121. Lonza Group: Business Segmentation in 2018
Table 122. Lonza Group: Product Portfolio
Table 123. Lonza Group: Revenue by Region in 2018
Table 124. Lupin Limited: Company Snapshot
Table 125. Lupin Limited: Business Segmentation
Table 126. Merck & Co., Inc.: Company Snapshot
Table 127. Merck & Co., Inc.: Business Segmentation
Table 128. Merck & Co., Inc.: Revenue, 2018-2020, $ bn
Table 129. Mylan NV: Company Snapshot
Table 130. Mylan NV: Revenue, 2017-2019, $ bn
Table 131. Novartis International AG: Company Snapshot
Table 132. Novartis International AG: Business Segmentation
Table 133. Novartis International AG: Revenue, 2017-2019, $ bn
Table 134. Pfizer Inc.: Company Snapshot
Table 135. Pfizer Inc.: Business Segmentation
Table 136. Pfizer Inc.: Product Portfolio
Table 137. Pfizer Inc.: Revenue, 2018-2020, $ bn
Table 138. Sanofi: Company Snapshot
Table 139. Sanofi: Business Segmentation
Table 140. Sanofi: Revenue, 2018-2020, $ bn
Table 141. Sun Pharmaceutical Industries Limited: Company Snapshot
Table 142. Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 143. Teva Pharmaceutical Industries Ltd.: Business Segmentation
Table 144. Thermo Fisher Scientific: Company Snapshot
Table 145. Risk Evaluation for Investing in Global Market, 2021-2028
Table 146. Critical Success Factors and Key Takeaways

List of Figures:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2028
Figure 4. Global Active Pharmaceutical Ingredients (API) Market, 2021-2028, $ bn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market
Figure 7. GDP per capita in the World, 1960-2018, $ thousand
Figure 8. Leading Causes of Death in the World, 2019-2020, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Five Forces Analysis of Global Active Pharmaceutical Ingredients (API) Market
Figure 14. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, % of Revenue
Figure 15. Contribution to Global 2022-2028 Cumulative Revenue by Synthesis, Value ($ bn) and Share (%)
Figure 16. Global Active Pharmaceutical Ingredients (API) Market: Synthetic API, 2018-2028, $ bn
Figure 17. Global Active Pharmaceutical Ingredients (API) Market: Branded Synthetic API, 2018-2028, $ bn
Figure 18. Global Active Pharmaceutical Ingredients (API) Market: Generic Synthetic API, 2018-2028, $ bn
Figure 19. Global Active Pharmaceutical Ingredients (API) Market: Biotech API, 2018-2028, $ bn
Figure 20. Global Active Pharmaceutical Ingredients (API) Market: Monoclonal Antibodies, 2018-2028, $ bn
Figure 21. Global Active Pharmaceutical Ingredients (API) Market: Recombinant Proteins, 2018-2028, $ bn
Figure 22. Global Active Pharmaceutical Ingredients (API) Market: Vaccines, 2018-2028, $ bn
Figure 23. Global Active Pharmaceutical Ingredients (API) Market: Other Biotech APIs, 2018-2028, $ bn
Figure 24. Global Active Pharmaceutical Ingredients (API) Market: Innovative Biologic API, 2018-2028, $ bn
Figure 25. Global Active Pharmaceutical Ingredients (API) Market: Generic Biosimilar API, 2018-2028, $ bn
Figure 26. Global Active Pharmaceutical Ingredients (API) Market: Mammalian Expression, 2018-2028, $ bn
Figure 27. Global Active Pharmaceutical Ingredients (API) Market: Microbial Expression, 2018-2028, $ bn
Figure 28. Global Active Pharmaceutical Ingredients (API) Market: Yeast Expression, 2018-2028, $ bn
Figure 29. Global Active Pharmaceutical Ingredients (API) Market: Insect Expression, 2018-2028, $ bn
Figure 30. Global Active Pharmaceutical Ingredients (API) Market: Other Expression Technologies, 2018-2028, $ bn
Figure 31. Global Active Pharmaceutical Ingredients (API) Market: HPAPI, 2018-2028, $ bn
Figure 32. Global Active Pharmaceutical Ingredients (API) Market: Branded HPAPI, 2018-2028, $ bn
Figure 33. Global Active Pharmaceutical Ingredients (API) Market: Generic HPAPI, 2018-2028, $ bn
Figure 34. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, % of Revenue
Figure 35. Contribution to Global 2022-2028 Cumulative Revenue by Manufacturing Process, Value ($ bn) and Share (%)
Figure 36. Global Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing, 2018-2028, $ bn
Figure 37. Global Active Pharmaceutical Ingredients (API) Market: Branded Captive API, 2018-2028, $ bn
Figure 38. Global Active Pharmaceutical Ingredients (API) Market: Generic Captive API, 2018-2028, $ bn
Figure 39. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing, 2018-2028, $ bn
Figure 40. Global Active Pharmaceutical Ingredients (API) Market: Branded Merchant API, 2018-2028, $ bn
Figure 41. Global Active Pharmaceutical Ingredients (API) Market: Generic Merchant API, 2018-2028, $ bn
Figure 42. Global Active Pharmaceutical Ingredients (API) Market: Merchant Synthetic API, 2018-2028, $ bn
Figure 43. Global Active Pharmaceutical Ingredients (API) Market: Merchant Biotech API, 2018-2028, $ bn
Figure 44. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, % of Revenue
Figure 45. Contribution to Global 2022-2028 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%)
Figure 46. Global Active Pharmaceutical Ingredients (API) Market: Infectious Diseases, 2018-2028, $ bn
Figure 47. Global Active Pharmaceutical Ingredients (API) Market: Oncology, 2018-2028, $ bn
Figure 48. Global Active Pharmaceutical Ingredients (API) Market: Ophthalmology , 2018-2028, $ bn
Figure 49. Global Active Pharmaceutical Ingredients (API) Market: Cardiovascular Disorders, 2018-2028, $ bn
Figure 50. Global Active Pharmaceutical Ingredients (API) Market: Central Nervous System, 2018-2028, $ bn
Figure 51. Global Active Pharmaceutical Ingredients (API) Market: Pulmonary Disorders, 2018-2028, $ bn
Figure 52. Global Active Pharmaceutical Ingredients (API) Market: Orthopedics, 2018-2028, $ bn
Figure 53. Global Active Pharmaceutical Ingredients (API) Market: Other Applications, 2018-2028, $ bn
Figure 54. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2018-2028, % of Revenue
Figure 55. Contribution to Global 2022-2028 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%)
Figure 56. Global Active Pharmaceutical Ingredients (API) Market: Branded Prescription Drugs, 2018-2028, $ bn
Figure 57. Global Active Pharmaceutical Ingredients (API) Market: Generic Prescription Drugs, 2018-2028, $ bn
Figure 58. Global Active Pharmaceutical Ingredients (API) Market: OTC Drugs, 2018-2028, $ bn
Figure 59. Global Market Snapshot by Region
Figure 60. Geographic Spread of Worldwide Active Pharmaceutical Ingredients (API) Market, 2018-2028, % of Revenue
Figure 61. Contribution to Global 2022-2028 Cumulative Revenue by Region, Value ($ bn) and Share (%)
Figure 62. North American Active Pharmaceutical Ingredients (API) Market, 2018-2028, $ bn
Figure 63. Breakdown of North America Active Pharmaceutical Ingredients (API) Market by Country, 2021 and 2028, % of Revenue
Figure 64. Contribution to North America 2022-2028 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 65. U.S. Active Pharmaceutical Ingredients (API) Market, 2018-2028, $ bn
Figure 66. Manufacturing Sites of APIs for U.S. Market by Country or Region,
Figure 67. Number and Percentage of API Facilities for the 370 U.S. Marketed Drugs on the 2019 WHO Essential Medicines List
Figure 68. Number and Percentage of API Facilities for the 370 U.S. Marketed Drugs on the 2019 WHO Essential Medicines List
Figure 69. Canada Active Pharmaceutical Ingredients (API) Market, 2018-2028, $ bn
Figure 70. Active Pharmaceutical Ingredients (API) Market in Mexico, 2018-2028, $ bn
Figure 71. European Active Pharmaceutical Ingredients (API) Market, 2018-2028, $ bn
Figure 72. Breakdown of European Active Pharmaceutical Ingredients (API) Market by Country, 2021 and 2028, % of Revenue
Figure 73. Contribution to Europe 2022-2028 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 74. Active Pharmaceutical Ingredients (API) Market in UK, 2018-2028, $ bn
Figure 75. Active Pharmaceutical Ingredients (API) Market in France, 2018-2028, $ bn
Figure 76. Active Pharmaceutical Ingredients (API) Market in Germany, 2018-2028, $ bn
Figure 77. Active Pharmaceutical Ingredients (API) Market in Spain, 2018-2028, $ bn
Figure 78. Active Pharmaceutical Ingredients (API) Market in Italy, 2018-2028, $ bn
Figure 79. Active Pharmaceutical Ingredients (API) Market in Russia, 2018-2028, $ bn
Figure 80. Active Pharmaceutical Ingredients (API) Market in Rest of Europe, 2018-2028, $ bn
Figure 81. Asia-Pacific Active Pharmaceutical Ingredients (API) Market, 2018-2028, $ bn
Figure 82. Breakdown of APAC Active Pharmaceutical Ingredients (API) Market by Country, 2021 and 2028, % of Revenue
Figure 83. Contribution to APAC 2022-2028 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 84. Active Pharmaceutical Ingredients (API) Market in China, 2018-2028, $ bn
Figure 85. Active Pharmaceutical Ingredients (API) Market in Japan, 2018-2028, $ bn
Figure 86. Active Pharmaceutical Ingredients (API) Market in India, 2018-2028, $ bn
Figure 87. Active Pharmaceutical Ingredients (API) Market in Australia, 2018-2028, $ bn
Figure 88. Active Pharmaceutical Ingredients (API) Market in South Korea, 2018-2028, $ bn
Figure 89. Active Pharmaceutical Ingredients (API) Market in Rest of APAC, 2018-2028, $ bn
Figure 90. South America Active Pharmaceutical Ingredients (API) Market, 2018-2028, $ bn
Figure 91. Breakdown of South America Active Pharmaceutical Ingredients (API) Market by Country, 2021 and 2028, % of Revenue
Figure 92. Contribution to South America 2022-2028 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 93. Active Pharmaceutical Ingredients (API) Market in Argentina, 2018-2028, $ bn
Figure 94. Active Pharmaceutical Ingredients (API) Market in Brazil, 2018-2028, $ bn
Figure 95. Active Pharmaceutical Ingredients (API) Market in Chile, 2018-2028, $ bn
Figure 96. Active Pharmaceutical Ingredients (API) Market in Rest of South America, 2018-2028, $ bn
Figure 97. Active Pharmaceutical Ingredients (API) Market in Rest of the World (RoW), 2018-2028, $ bn
Figure 98. Breakdown of RoW Active Pharmaceutical Ingredients (API) Market by Country, 2021 and 2028, % of Revenue
Figure 99. Contribution to RoW 2022-2028 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 100. Active Pharmaceutical Ingredients (API) Market in UAE, 2018-2028, $ bn
Figure 101. Active Pharmaceutical Ingredients (API) Market in Saudi Arabia, 2018-2028, $ bn
Figure 102. Active Pharmaceutical Ingredients (API) Market in South Africa, 2018-2028, $ bn
Figure 103. Growth Stage of Global Active Pharmaceutical Ingredients (API) Industry over the Forecast Period
Figure 104. Top products of AstraZeneca based on revenue from 2016 to 2019 (in million U.S. dollars)

Companies Mentioned

  • Selected Key Players:
  • AbbVie Inc.
  • Astrazeneca
  • Aurobindo Pharma Ltd.
  • BASF
  • Bayer AG
  • Boehringer Ingelheim
  • Catalent Inc.
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche
  • GlaxoSmithKline plc
  • Lonza Group
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific

Methodology

Loading
LOADING...